The IPO market is raising record money while the smallest deals quietly disappear

by Imogen Farrow · August 12, 2026

Listings Reporter, The MicroCap Herald

The 2026 new-issue market has become one of the most lopsided on record, and the imbalance matters most at the end of the size spectrum this publication covers. Renaissance Capital's IPO statistics page reports 99 IPOs priced so far this year, a 25.6% decline from the same point last year, while total proceeds reached $145.3 billion — an increase of 553.1%. Fewer companies are going public, and the ones that do are raising vastly more. Renaissance also counts 140 SPAC IPOs, more than any other sector category.

August's pricings show the shape of that barbell in miniature. Renaissance's recently priced list for the month includes Braveheart Bio at a $383 million deal size on August 5, Latigo Biotherapeutics at $346 million and BlossomHill Therapeutics at $150 million on August 6, Attovia Therapeutics at $289 million on August 4, and River City Bank at $122 million on August 5. Only one deal in the group came in under $50 million: Ticketplus, the Chilean live-event ticketing platform, at $15 million on August 6, which Renaissance showed trading 5.1% below its offering price.

The disappearance of the tier below that is more dramatic than the headline count suggests. A Fast Company investigation published July 16 by Jennifer Mattson reported that only 13 micro-cap IPOs had come to Nasdaq or the NYSE in 2026 to date, together raising under $300 million — against 80 such offerings in 2025. The article described a category that between 2010 and 2025 typically brought companies public at market values between $5 million and $30 million, and framed its contraction against SpaceX's $85.7 billion raise as evidence of a widening funding gap.

The proximate cause is regulatory, and the rulebook has moved fast. A summary from Torres Business Law reports that the SEC approved Nasdaq amendments on December 18, 2025, effective January 17, 2026, setting a unified $15 million minimum public float for companies listing under the net income standard on both the Global Market and the Capital Market — up from prior thresholds of $8 million and $5 million respectively. The stated rationale was to ensure a larger pool of freely tradable shares and more robust liquidity at the point of listing.

A parallel change altered how that float is even counted. Harter Secrest & Emery's review of Nasdaq's listing standards notes an SEC-approved rule under which only capital raised directly in the IPO or uplisting offering counts toward the public float minimum, replacing an approach that allowed previously issued freely tradeable shares to be included. The same review flags a further proposal, still pending at the SEC as of its publication, that would raise the net income standard itself to $15 million. Taken together, the changes mean a company cannot reach the listing threshold by counting shares it distributed before the deal.

Nasdaq has also given itself discretion that no numerical test can satisfy. Gunderson Dettmer's analysis of Rule IM-5101-3, approved by the SEC on December 19, 2025 and effective immediately, describes a standard permitting the exchange to deny an initial listing application even when a company meets every quantitative requirement, on the basis of factors that make its securities more susceptible to manipulation. The eight non-exclusive factors include the company's jurisdiction and the availability of legal remedies there, where controlling persons sit relative to regulators, float adequacy and share concentration, the regulatory history of the company's auditors, underwriters, law firms and brokers, management's familiarity with US public-company obligations, referrals from FINRA or the SEC, going-concern audit opinions, and general integrity concerns. Gunderson notes Nasdaq intended to apply the rule to every company already in the application pipeline.

Enforcement has accompanied the rulemaking. Fast Company reported that Nasdaq halted trading in more than a dozen firms over the past year and that Hong Kong-based QMMM Holdings Ltd. received a delisting notification in June 2026, with regulators citing apparent pump-and-dump schemes, many originating in Asia. A separate Nasdaq proposal summarized by Torres Business Law and still under SEC review would impose a $25 million minimum offering size on companies headquartered, incorporated or principally administered in China, Hong Kong or Macau — covering IPOs, de-SPAC transactions, direct listings and transfers from the OTC market or other exchanges — and would bar those issuers from direct listings on the Capital Market entirely.

There is a genuine trade-off embedded in all of this, and it is worth stating without taking a side. The rules were written to attack a real problem: thinly floated listings that were straightforward to manipulate and that left retail buyers holding losses. They also close off the public markets to companies whose legitimate capital needs are measured in single-digit millions, a range that no longer clears any Nasdaq initial listing standard. For readers of this publication, the practical consequence is that the supply of new micro-cap listings is contracting, that the ones that do price face heavier scrutiny and larger minimum raises, and that a company arriving under the current regime has had to clear a materially higher bar than one that listed three years ago — which tells you about the entry requirements, and nothing about the business.